Paxil CR, Avandamet Seizure Threatens $1 Bil. In Annual Revenue For GSK
FDA's seizure of GlaxoSmithKline's Paxil CR and Avandamet threatens $1 bil. in annual revenues for the company
FDA's seizure of GlaxoSmithKline's Paxil CR and Avandamet threatens $1 bil. in annual revenues for the company